Courses

Cancer microenvironment

The course surveys of the essential traits of a malignant cell and the involvement of the cancer microenvironment in their acquisition. The signaling pathways between the cancer cells and their immediate and remote surroundings is reviewed. Examples from both solid and hematological tumors are presented. Special attention to historical context is awarded and the future directions are highlighted and discussed. Course contents are up to date and include the most recent and developing aspects as well.

TAU sylabus

Courses

Select Publications

Ribosomal proteins as distinct “passengers” of microvesicles: new semantics in myeloma and mesenchymal stem cells’ communication

Multiple myeloma BM-MSCs increase the tumorigenicity of MM cells via transfer of VLA4-enriched microvesicles

BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

The effect of mesenchymal stem cells' secretome on lung cancer progression is contingent on their origin: primary or metastatic niche

Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation

Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation

Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation

Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation

Targeting eIF4GI translation initiation factor affords an attractive therapeutic strategy in multiple myeloma

eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling

Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E